Vanguard Personalized Indexing Management, LLC Ventyx Biosciences, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $8.6 Billion
- Q2 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 46,711 shares of VTYX stock, worth $393,306. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,711
Previous 22,883
104.13%
Holding current value
$393,306
Previous $26,000
280.77%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding VTYX
# of Institutions
120Shares Held
49.4MCall Options Held
70.4KPut Options Held
51.4K-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.9MShares$49.6 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.77MShares$40.2 Million0.0% of portfolio
-
Affinity Asset Advisors, LLC New York, NY4.54MShares$38.2 Million1.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.16MShares$26.6 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA3.1MShares$26.1 Million0.4% of portfolio
About Ventyx Biosciences, Inc.
- Ticker VTYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,527,200
- Market Cap $476M
- Description
- Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...